Early detection of recurrent prostate cancer with an ultrasensitive chemiluminescent prostate-specific antigen assay

Urology

Volumn 50, Issue 4, 1997, Pages 573-579

  Ellis, William J ^a   Vessella, Robert L ^b   Noteboom, Jennifer L ^b   Lange, Paul H ^b   Wolfert, Robert L ^b   Rittenhouse, Harry G ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ANTIGEN DETECTION; ARTICLE; CANCER RECURRENCE; CHEMOLUMINESCENCE; CONTROLLED STUDY; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; LATENT PERIOD; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; REGRESSION ANALYSIS; TREATMENT FAILURE;

CHEMILUMINESCENT MEASUREMENTS; FEMALE; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 0030839625     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(97)00251-3     Document Type: Article

References (23)

1. Ellis WJ, and Brawer MK: The role of tumor markers in the diagnosis and treatment of prostate cancer, in Lepor H, and Lawson RK (Eds): Prostate Diseases. Philadelphia, WB Saunders, 1993, pp 276-291.
2. Oesterling JE: Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 145: 907-923, 1991.
3. Takayama TK, Vessella RL, Brawer MK, Noteboom J, and Lange PH: The enhanced detection of persistent disease after prostatectomy with a new PSA immunoassay. J Urol 150: 374-378, 1993.
4. Chan DW, Bruzek DJ, Oesterling JE, Rock RC, and Walsh PC: Prostate-specific antigen as a marker for prostatic cancer: a monoclonal and polyclonal immunoassay compared. Clin Chem 33: 1916-1920, 1987.
5. Vessella RL, Noteboom J, and Lange PH: Evaluation of the Abbott IMx automated immunoassay of PSA. Clin Chem 38: 2044-2054, 1992.
6. Vessella R, and Lange P: Issues in the assessment of PSA immunoassays. Urol Clin North Am 20: 607-619, 1993.
7. Stamey TA, Graves H, Wehner N, Ferrari M, and Freiha FS: Early detection of residual prostate cancer after radical prostatectomy by an ultrasensitive assay for prostate specific antigen. J Urol 149: 787-792, 1993.
8. Prestigiacomo A, and Stamey T: A comparison of 4 ultrasensitive prostate specific antigen assays for early detection of residual cancer after radical prostatectomy. J Urol 152: 1515-1519, 1994.
9. Yu H, and Diamandis E: Ultrasensitive time-resolved immunofluorometric assay of prostate-specific antigen in the serum and preliminary clinical studies. Clin Chem 39: 2108-2114, 1993.
10. Yu H, and Diamandis EP: Measurement of serum prostate specific antigen levels in women and in prostatectomized men with an ultrasensitive immunoassay technique. J Urol 153: 1004-1008, 1995.
11. Dodson MK, Cliby WA, Keeney GL, Peterson M, and Podratz K: Skene's gland adenocarcinoma with increased serum level of prostate specific antigen. Gynecol Oncol 5: 304-307, 1994.
12. Pollen JJ, and Dreilinger A: Immunohistochemical identification of prostatic acid phosphatase and PSA in female periurethral glands. Urology 23: 303-304, 1984.
13. Tepper SL, Jagirdar J, Heath D, and Geller SA: Homology between the female paraurethral (Skene's) glands and the prostate. Immunohistochemical demonstration. Arch Pathol Lab Med 108: 423-425, 1984.
14. Kamoshida S, and Tsutumi Y: Extraprostatic localization of prostatic acid phosphatase and prostate specific antigen: distribution in cloacogenic glandular epithelium and sex-dependent expression in human anal gland. Hum Pathol 21: 1108-1111, 1990.
15. Spencer JR, Brodin AG, and Ignatoff JM: Clear cell adenocarcinoma of the urethra: evidence for origin within paraurethral ducts. J Urol 143: 122-125, 1990.
16. Yu H, and Diamandis E: Prostate-specific antigen in milk of lactating women. Clin Chem 41: 54-58, 1995.
17. Takayama TK, Vessella RL, Brawer MK, True LD, Noteboom J, and Lange PH: Urinary PSA levels after radical prostatectomy. J Urol 151: 82-87, 1994.
18. Frazier HA, Humphrey PA, Burchette JL, and Paulson DF: Immunoreactive prostatic specific antigen in male periurethral glands. J Urol 147: 246-248, 1992.
19. Bromberg WD, Kozlowski JM, and Oyasu R: Prostate-type gland in the epididymis. J Urol 145: 1273-1274, 1991.
20. Oesterling JE, Tekchandani AH, Martin SK, Bergstralh EJ, Reichstein E, Diamandis EP, Vemoto C, and Stamey TA: The periurethral glands do not significantly influence the serum prostate specific antigen concentration. J Urol 155: 1658-1660, 1996.
21. Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, and Redwine E: Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 317: 909-916, 1987.
22. Oesterling JE, Chan DW, Epstein JI, Kimball AW Jr, Brozek DJ, Rock RC, Brendler CB, and Walsh PC: Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy. J Urol 139: 766-772, 1988.
23. Ellis WJ, and Lange PH: Managing patients with pathologic C disease and elevated PSA levels after radical prostatectomy. Prob Urol 7: 191-204, 1993.